 Cutaneous hypersensitivity reactions due seropositive patients tuberculosis effects human immunodeficiency virus HIV tuberculosis management patients regimen streptomycin isoniazid thiacetazone STH HIV-seropositive patients HIV-seropositive regimen streptomycin isoniazid rifampicin pyrazinamide SHRZ initial phase thiacetazone isoniazid TH continuation phase Cutaneous hypersensitivity reactions patients patients RR CI first weeks treatment reactions HIV-seropositive patients STH reaction HIV-seropositive patients initial phase SHRZ/TH None HIV-seropositive patients cutaneous reactions isoniazid streptomycin thiacetazone patients HIV-positive toxic epidermal necrolysis result cutaneous reaction results major implications tuberculosis control Africa